Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALFALYTE is an oral rehydration solution (ORS) developed and distributed by Biotech Pharmaceuticals. It is a balanced electrolyte formulation containing essential minerals such as sodium, potassium, and chloride, combined with carbohydrates to facilitate the absorption of water and electrolytes in the gastrointestinal tract. ALFALYTE is indicated for the restoration of fluids and electrolytes lost due to diarrhea, vomiting, or physical exertion in infants, children, and adults. As a supportive care product, it functions by replenishing the body's fluid balance and preventing dehydration rather than targeting a specific biological pathway or pathogen. It is available as a ready-to-drink liquid solution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ALFALYTE.